---
title: "August 30–31 VC News: Dexterous Robots, Heterogeneous Inference, World Models, Clinical Agents"
description: "Gap-fill investment explainers for the Aug 18–28 tape still missing deep pages: Sharpa ~$670M, Callosum $100M seed, Veeda $90M+, Faro $37.3M, Multiplier $6M (Lux/YC asset managers), and Hubble $30M B-II — who uses the products and why these syndicates fit."
date: 2026-08-31T00:00:00.000Z
tags: ["2026-vc-news", "venture-capital", "startup-funding", "artificial-intelligence", "robotics", "healthtech", "fintech", "space-tech", "market-analysis"]
source: https://venturecapitaltracker.com/2026-august-30-31-investment-news-robots-inference-world-models
---

# August 30–31 VC News: Dexterous Robots, Heterogeneous Inference, World Models, Clinical Agents

> Gap-fill investment explainers for the Aug 18–28 tape still missing deep pages: Sharpa ~$670M, Callosum $100M seed, Veeda $90M+, Faro $37.3M, Multiplier $6M (Lux/YC asset managers), and Hubble $30M B-II — who uses the products and why these syndicates fit.

**August 30–31, 2026 did not drop a fresh US mega-tape.** The gap-fill is six deals from **Aug 18–28** that still lacked Tracker deep pages after the Aug 25–30 batches: [Sharpa](/startup/sharpa) **~$670M**, [Callosum](/startup/callosum) **$100M** seed, [Veeda](/startup/veeda) **$90M+**, [Faro](/startup/faro-ai) **$37.3M**, [Multiplier](/startup/multiplier-asset-managers) **$6M** (Lux/YC), and [Hubble Network](/startup/hubble-network) **$30M**.

**Unexpected truth:** the consequential story this weekend is **physical AI + inference economics** — dexterous hands in Shanghai, chip routing in London, world models in Toronto — not another consumer-agent valuation print.

This index is for founders and scouts who need those six facts with caveats. Last verified **August 31, 2026**. It does not rehash [Aug 29–30 Palona/HubX](/2026-august-29-30-investment-news-restaurant-apps-trust) or [AusperBio](/2026-august-29-30-investment-news-biotech-robotics-docs).

## What this pass adds

| Company | Amount | Lead / key | Tracker `/fund/` | Why it matters |
| --- | --- | --- | --- | --- |
| [Sharpa](/2026-sharpa-670m-alibaba-tencent-dexterous-robots) | ~$670M / >¥4.5B | Alibaba, Tencent, Meituan, JD, HongShan | none | Hesai founders; Wave hands + DQ robot restaurant |
| [Callosum](/2026-callosum-100m-seed-atomico-heterogeneous-ai) | $100M seed | Atomico; Plural, DCVC, UK Sovereign AI | none | Route each AI task to the right chip |
| [Veeda](/2026-veeda-90m-seed-khosla-radical-world-models) | $90M+ seed | Khosla + Radical | [Khosla](/fund/khosla-ventures) | Fidler world models; Canada mega-seed |
| [Faro](/2026-faro-37-3m-series-b-merck-s32-general-catalyst) | $37.3M B | Merck GHI + S32; GC returning | [General Catalyst](/fund/general-catalyst) | 6/10 top pharma; clinical agents |
| [Multiplier](/2026-multiplier-6m-seed-lux-yc-asset-managers) | $6M seed | Lux + YC | [Lux](/fund/lux-capital), [YC](/fund/y-combinator) | Asset-manager harnesses (≠ pro-services Multiplier) |
| [Hubble](/2026-hubble-network-30m-series-b-ii-seraphim) | $30M B-II | Seraphim SSIT | [YC](/fund/y-combinator) historical | Satellite BLE; 7 sats on orbit |

## Who uses these products (one line each)

- **Sharpa** — robot OEMs + retail automation (DQ); dexterous Wave hands in mass production.
- **Callosum** — agentic FS workloads on Cerebras; developers adopting heterogeneous silicon without rewrites.
- **Veeda** — no named customers yet; target is teams training embodied agents in simulation.
- **Faro** — six of the ten largest pharma clinical-development orgs (company).
- **Multiplier** — Mercator, Verso, and peer asset managers needing firm-specific agent evals.
- **Hubble** — Life360, Tile, TI, InPlay, Samsara partnership surface for BLE asset tracking.

## Why these funds wrote the checks (judgment)

| Deal | Likely portfolio fit |
| --- | --- |
| Sharpa | China platforms buying physical-AI infrastructure after model-only years |
| Callosum | European + sovereign bet that inference routing beats monoculture GPUs |
| Veeda | Khosla/Radical doubling world-model research tickets (Waabi, World Labs adjacency) |
| Faro | Strategic pharma capital + GC continuity into agentic clinical workflows |
| Multiplier | Lux frontier systems + CIO angels who are also buyers |
| Hubble | Seraphim multi-stage SpaceTech: SSVII → SSIT C Share follow-on |

## Explicitly skipped this pass

- **Perceptron “$21M”** — TechCrunch corrected funding details; PitchBook path shows prior **$16M** and an additional round still closing. Product launch (Isaac 0.5) is real; amount not locked here.
- **SiteVue $7.5M**, **ColibriTD €4M**, **Arrakis $30M** — still thin `/fund/` coverage or older July stealth; candidates for a later batch.
- **Town / General Intuition** mega marks — wait for closed disclosures (prior memory).

## Read next

1. [Sharpa ~$670M](/2026-sharpa-670m-alibaba-tencent-dexterous-robots) — dexterous hands
2. [Callosum $100M](/2026-callosum-100m-seed-atomico-heterogeneous-ai) — heterogeneous inference
3. [Veeda $90M+](/2026-veeda-90m-seed-khosla-radical-world-models) — world models
4. [Faro $37.3M](/2026-faro-37-3m-series-b-merck-s32-general-catalyst) — clinical agents
5. [Multiplier $6M](/2026-multiplier-6m-seed-lux-yc-asset-managers) — asset-manager AI
6. [Hubble $30M](/2026-hubble-network-30m-series-b-ii-seraphim) — space BLE

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** August 31, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.